Neoadjuvant immune checkpoint inhibition protects from hepatic melanoma metastasis by mounting an enhanced anti-tumoral Th1 immune response

被引：0
|
作者：
Wohlfeil, S. A. [1 ,2 ,3 ]
Weller, C. [1 ,2 ,3 ]
Dietsch, B. [1 ,2 ,3 ]
Agardy, D. A. [4 ]
Boschert, T. [4 ]
Haefele, V. [1 ,2 ,3 ]
Platten, M. [4 ,5 ]
Goerdt, S. [1 ,2 ,6 ]
Geraud, C. [1 ,2 ,3 ]
机构：
[1] Heidelberg Univ, Univ Med Ctr, Dept Dermatol Venereol & Allergol, Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany
[3] Heidelberg Univ, Med Fac Mannheim, Sect Clin & Mol Dermatol, Mannheim, Germany
[4] German Canc Res Ctr, DKTK Clin Cooperat Unit CCU Neuroimmunol & Brain, Heidelberg, Germany
[5] Heidelberg Univ, Med Fac Mannheim, Dept Neurol, MCTN, Mannheim, Germany
[6] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, Mannheim, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2024年 / 33卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P155
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant immune checkpoint inhibition prevents resistance mechanisms of hepatic melanoma metastases and induces an enhanced Th1 immune response
    Wohlfeil, S.
    Weller, C.
    Dietsch, B.
    Haefele, V.
    Goerdt, S.
    Geraud, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 3 - 4
  • [2] Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
    Dmello, Crismita
    Zhao, Junfei
    Chen, Li
    Gould, Andrew
    Castro, Brandyn
    Arrieta, Victor A.
    Zhang, Daniel Y.
    Kim, Kwang-Soo
    Kanojia, Deepak
    Zhang, Peng
    Miska, Jason
    Yeeravalli, Ragini
    Habashy, Karl
    Saganty, Ruth
    Kang, Seong Jae
    Fares, Jawad
    Liu, Connor
    Dunn, Gavin
    Bartom, Elizabeth
    Schipma, Matthew J.
    Hsu, Patrick D.
    Alghamri, Mahmoud S.
    Lesniak, Maciej S.
    Heimberger, Amy B.
    Rabadan, Raul
    Lee-Chang, Catalina
    Sonabend, Adam M.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [3] Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
    Crismita Dmello
    Junfei Zhao
    Li Chen
    Andrew Gould
    Brandyn Castro
    Victor A. Arrieta
    Daniel Y. Zhang
    Kwang-Soo Kim
    Deepak Kanojia
    Peng Zhang
    Jason Miska
    Ragini Yeeravalli
    Karl Habashy
    Ruth Saganty
    Seong Jae Kang
    Jawad Fares
    Connor Liu
    Gavin Dunn
    Elizabeth Bartom
    Matthew J. Schipma
    Patrick D. Hsu
    Mahmoud S. Alghamri
    Maciej S. Lesniak
    Amy B. Heimberger
    Raul Rabadan
    Catalina Lee-Chang
    Adam M. Sonabend
    Nature Communications, 14
  • [4] Commonly Used Drugs in Rheumatology May Alter Anti-Tumoral Response to Immune Checkpoint Inhibitors
    Kostine, Marie
    Mauric, Eleonora
    Barnetche, Thomas
    Rouxel, Lea
    Dutriaux, Caroline
    Dousset, Lea
    Prey, Sorilla
    Beylot-Barry, Marie
    Seneschal, Julien
    Veillon, Remi
    Charlotte, Vergnenegre
    Daste, Amaury
    Charlotte, Domblides
    Sionneau, Baptiste
    Gross-Goupi, Marine
    Ravaud, Alain
    Forcade, Edouard
    Bannwarth, Bernard
    Mehsen-Cetre, Nadia
    Truchetet, Marie-Elise
    Richez, Christophe
    Schaeverbeke, Thierry
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] iNKT mediated anti-tumoral response activated by a Th1 biased agonist
    Esteban, I
    Alari-Pahissa, E.
    Lauzurica, P.
    Castano, A. R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 758 - 758
  • [6] COMMONLY USED DRUGS IN RHEUMATOLOGY MAY ALTER ANTI-TUMORAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS
    Kostine, Marie
    Mauric, Eleonora
    Barnetche, Thomas
    Rouxel, Lea
    Dutriaux, Caroline
    Dousset, Lea
    Prey, Sorilla
    Beylot-Barry, Marie
    Seneschal, Julien
    Veillon, Remi
    Vergnenegre, Charlotte
    Daste, Amaury
    Domblides, Charlotte
    Sionneau, Baptiste
    Gross-Goupil, Marine
    Ravaud, Alain
    Forcade, Edouard
    Bannwarth, Bernard
    Truchetet, Marie-Elise
    Richez, Christophe
    Mehsen-Cetre, Nadia
    Schaeverbeke, Thierry
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 251 - 251
  • [7] Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy
    Carbone, Maria Luigia
    Capone, Alessia
    Guercio, Marika
    Reddel, Sofia
    Silvestris, Domenico Alessandro
    Lulli, Daniela
    Ramondino, Carmela
    Peluso, Daniele
    Quintarelli, Concetta
    Volpe, Elisabetta
    Failla, Cristina Maria
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
    Cooper, Zachary A.
    Juneja, Vikram R.
    Sage, Peter T.
    Frederick, Dennie T.
    Piris, Adriano
    Mitra, Devarati
    Lo, Jennifer A.
    Hodi, Stephen
    Freeman, Gordon J.
    Bosenberg, Marcus W.
    McMahon, Martin
    Flaherty, Keith T.
    Fisher, David E.
    Sharpe, Arlene H.
    Wargo, Jennifer A.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 643 - 654
  • [9] CALORIC RESTRICTION SENSITIZES MELANOMA TO ANTI-PD-1 IMMUNE CHECKPOINT INHIBITION
    Melucci, Alexa
    Qin, Shuyang
    Chacon, Alexander
    Jewell, Rachel
    Prieto, Peter
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A618 - A618
  • [10] Telocinobufagin enhances the Th1 immune response and protects against Salmonella typhimurium infection
    Wu, Shuai-Cheng
    Fu, Ben-Dong
    Shen, Hai-Qing
    Yi, Peng-Fei
    Zhang, Li-Yan
    Lv, Shuang
    Guo, Xun
    Xia, Fang
    Wu, Yong-Li
    Wei, Xu-Bin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 25 (02) : 353 - 362
12345